<DOC>
	<DOCNO>NCT02468102</DOCNO>
	<brief_summary>This prospective cohort study provide information : Characteristics Rivaroxaban use patient prescribe Rivaroxaban first time compare patient prescribed standard care first time . The occurrence intracranial haemorrhage , gastrointestinal urogenital bleeding , occurrence non-infective liver disease .</brief_summary>
	<brief_title>Study Rivaroxaban Use Potential Adverse Outcomes Routine Clinical Practice ( Sweden )</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>All male female patient fill prescription rivaroxaban , warfarin , aspirin , clopidogrel , ticlopidine , prasugrel ticagrelor pharmacy Sweden , December 9 , 2011 December 31 , 2018 For AF DVT/PE treatment indication , patient fill prescription warfarin another oral anticoagulant time July 1 , 2005 December 9 , 2011 exclude</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rivaroxaban</keyword>
	<keyword>Venous Thrombosis/Pulmonary Embolism</keyword>
	<keyword>Stroke Prevention Atrial Fibrillation</keyword>
	<keyword>Anticoagulants</keyword>
	<keyword>Hematologic Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Observational</keyword>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Venous Thrombosis</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Intracranial Hemorrhages</keyword>
	<keyword>Gastrointestinal Hemorrhage</keyword>
</DOC>